Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII
The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) b…
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Estimated
~$10 – $8,750
Black Diamond Therapeutics, Inc.NCT07326566
Phase 1
Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your month…
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Estimated
~$10 – $7,500
Northwell HealthNCT03213002